Coorens, Tim H. H. http://orcid.org/0000-0002-5826-3554
Spencer Chapman, Michael http://orcid.org/0000-0002-5320-8193
Williams, Nicholas
Martincorena, Inigo http://orcid.org/0000-0003-1122-4416
Stratton, Michael R.
Nangalia, Jyoti http://orcid.org/0000-0001-7122-4608
Campbell, Peter J. http://orcid.org/0000-0002-3921-0510
Funding for this research was provided by:
Wellcome Trust
European Molecular Biology Organization (ALTF 172-2022)
Article History
Received: 23 November 2022
Accepted: 13 December 2023
First Online: 23 February 2024
Competing interests
: P.J.C., M.R.S. and I.M. are cofounders and stock holders of, and consultants for, Quotient Therapeutics Ltd.